Benjamin Trzaskoma

3.6k citations

49 papers · 2.4k indexed · 1 hit paper · h-index 21

Impact in

Immunology and Allergy top 2%
- Allergic Rhinitis and Sensitization
Critical Care and Intensive Care Medicine top 2%

Papers in

Immunology and Allergy 16
- Allergic Rhinitis and Sensitization 16
Physiology 32
- Asthma and respiratory diseases 32

Co-authors: Karin Rosén William L. Macias Bradley E. Chipps William W. Busse Theodore A. Omachi Allan T. Luskin Thomas B. Casale Jean‐Louis Vincent
Journals: Journal of Allergy and Clinical Immunology (17 papers)CHEST Journal (5 papers)Annals of Allergy Asthma & Immunology (4 papers)The Journal of Allergy and Clinical Immunology In Practice (3 papers)Respiratory Medicine (2 papers)
Partner nations: United States Switzerland France

In The Last Decade

Benjamin Trzaskoma

48 papers receiving 2.3k citations

Hit Papers

align trajectories log scale

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death 2005 · 567 citations

Peers

Countries citing papers authored by Benjamin Trzaskoma

Since Specialization

Citations

This map shows the geographic impact of Benjamin Trzaskoma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Trzaskoma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Trzaskoma more than expected).

Fields of papers citing papers by Benjamin Trzaskoma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Trzaskoma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Trzaskoma. The network helps show where Benjamin Trzaskoma may publish in the future.

Co-authors

The 25 scholars most cited alongside Benjamin Trzaskoma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin Trzaskoma Line = papers co-authored together Benjamin Trzaskoma links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma Respiratory Medicine ·一郎岡野, Great Lakes, Cécile Holweg, 山本雄平, Bob Gravestijn, John W. Steinke, Benjamin Trzaskoma, Nicola A. Hanania, Thomas B. Casale	2024	2
2	Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthma Annals of Allergy Asthma & Immunology ·William W. Busse, Marc Humbert, Tmirah Haselkorn, Benjamin Ortiz, Benjamin Trzaskoma, Patricia Stephenson, Lorena Garcia Conde, Farid Kianifard, Stephen T. Holgate	2019	34
3	Factor VIII Use in the Treatment of Breakthrough Bleeds in Hemophilia A Patients without Inhibitors on Emicizumab Prophylaxis: The Phase 3 HAVEN 3 Study Experience Blood ·Michael U. Callaghan, Benjamin Trzaskoma, Richard H. Ko, А.С. Боровик-Романов, Anisha M. Patel, Stuart A. Caplan, Mahla Lashkari, Tiffany Chang, Markus Niggli, Christophe Dhalluin, Johnny Mahlangu	2019	5
4	Decreased Asthma Exacerbations and Hospitalizations in PROSPERO (Prospective Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab) Journal of Allergy and Clinical Immunology ·Rozhdestvensky A. M., William W. Busse, Allan T. Luskin, Robert S. Zeiger, Benjamin Trzaskoma, Noelle M. Griffin, Evgeniya Antonova, Susan L. Limb, Thomas B. Casale	2017	2
5	Asthma Exacerbations and Triggers in Children in TENOR: Impact on Quality of Life The Journal of Allergy and Clinical Immunology In Practice ·Bradley E. Chipps, Tmirah Haselkorn, Karin Rosén, David R. Mink, Benjamin Trzaskoma, Allan T. Luskin	2017	25
6	Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience Journal of Allergy and Clinical Immunology ·Bradley E. Chipps, Bob Lanier, Henry Milgrom, A. Deschildre, Gunilla Hedlin, Stanley J. Szefler, Meyer Kattan, Farid Kianifard, Benjamin Ortiz, Tmirah Haselkorn, Ahmar Iqbal, Karin Rosén, Benjamin Trzaskoma, William W. Busse	2017	115
7	Poor Asthma Control Is Associated with Overall Daily Activity Impairment: 3-Year Data from the EXCELS Study of Omalizumab Journal of Allergy and Clinical Immunology ·Evgeniya Antonova, Benjamin Trzaskoma, Theodore A. Omachi, Michael Schätz	2016	4
8	A randomized multicenter study evaluating Xolair persistence of response after long-term therapy Journal of Allergy and Clinical Immunology ·Dennis K. Ledford, William W. Busse, Benjamin Trzaskoma, Theodore A. Omachi, Karin Rosén, Bradley E. Chipps, Allan T. Luskin, Paul G. Solari	2016	146
9	Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies Annals of Allergy Asthma & Immunology ·James L. Zazzali, Allen P. Kaplan, Marcus Maurer, Karina Raimundo, Benjamin Trzaskoma, Paul G. Solari, Evgeniya Antonova, Meryl H. Mendelson, Karin Rosén	2016	20
10	Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies Clinical and Translational Allergy ·Ana M. Giménez‐Arnau, Sheldon L. Spector, Evgeniya Antonova, Benjamin Trzaskoma, Karin Rosén, Theodore A. Omachi, Donald E. Stull, Maria‐Magdalena Balp, Thomas Murphy	2016	25
11	Omalizumab adherence in an observational study of patients with moderate to severe allergic asthma Annals of Allergy Asthma & Immunology ·Susan Janson, Paul G. Solari, Benjamin Trzaskoma, Hubert Chen, Tmirah Haselkorn, James L. Zazzali	2015	19
12	Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis Journal of Cystic Fibrosis ·Clement L. Ren, Michael W. Konstan, Ashley Yegin, Lawrence Rasouliyan, Benjamin Trzaskoma, Wayne J. Morgan, Warren E. Regelmann	2012	45
13	Concomitant asthma medications in moderate-to-severe allergic asthma treated with omalizumab Respiratory Medicine ·Hubert Chen, Mark D. Eisner, Tmirah Haselkorn, Benjamin Trzaskoma	2012	17
14	Severity of Asthma Score Predicts Clinical Outcomes in Patients With Moderate to Severe Persistent Asthma CHEST Journal ·Mark D. Eisner, Ashley Yegin, Benjamin Trzaskoma	2011	46
15	Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial Arthritis & Rheumatism ·Clifton O. Bingham, R. John Looney, Atul Deodhar, Neal A. Halsey, Maria Greenwald, Christine E. Codding, Benjamin Trzaskoma, Flavius Martin, Sunil Agarwal, Ariella Kelman	2009	324
16	ADDRESS (ADministration of DRotrecogin alfa [activated] in Early stage Severe Sepsis) long-term follow-up: One-year safety and efficacy evaluation* Critical Care Medicine ·Pierre‐François Laterre, Edward Abraham, Jonathan Janes, Benjamin Trzaskoma, B. Spalding-Yoder, Frank V. McL. Booth	2007	27
17	Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis Critical Care ·Jean‐Louis Vincent, James M. O’Brien, Arthur P. Wheeler, Xavier Wittebole, Rekha Garg, Benjamin Trzaskoma, David P. Sundin	2006	32
18	International INtegrated Database for the Evaluation of severe sePsis and drotrecogin alfa (activated) THerapy: component trials and statistical methods for INDEPTH Current Medical Research and Opinion ·Andreas Sashegyi, Benjamin Trzaskoma, David R. Nelson, Mark D. Williams, William L. Macias	2006	8
19	Early changes in organ function predict eventual survival in severe sepsis* Critical Care Medicine ·Mitchell M. Levy, William L. Macias, Jean‐Louis Vincent, James A. Russell, Eliezer Silva, Benjamin Trzaskoma, Mark D. Williams	2005	252
20	Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death New England Journal of Medicine ·Edward Abraham, Pierre‐François Laterre, Rekha Garg, Howard Levy, Deepak Talwar, Benjamin Trzaskoma, Bruno François, Jeffrey S. Guy, Martina Brückmann, Álvaro Réa-Neto, Rolf Rossaint, D. Perrotin, Armin Sablotzki, Joseph I. Ubah, Barbara G. Utterback, William L. Macias Hit paper breakdown →	2005	567

About Benjamin Trzaskoma

Benjamin Trzaskoma is a scholar working on Immunology and Allergy, Physiology, Pulmonary and Respiratory Medicine, Rheumatology and Critical Care and Intensive Care Medicine, having authored 49 papers that have together received 2.4k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (32 papers), Allergic Rhinitis and Sensitization (16 papers), Respiratory and Cough-Related Research (13 papers), Inhalation and Respiratory Drug Delivery (11 papers), Urticaria and Related Conditions (9 papers), Sepsis Diagnosis and Treatment (6 papers), Pharmaceutical studies and practices (4 papers) and Autoimmune Bullous Skin Diseases (3 papers). The work is most often cited by research in Immunology and Allergy (330 citations), Critical Care and Intensive Care Medicine (269 citations), Physiology (822 citations), Rheumatology (408 citations) and Family Practice (55 citations). Benjamin Trzaskoma has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Karin Rosén, William L. Macias, Bradley E. Chipps, William W. Busse, Theodore A. Omachi, Allan T. Luskin, Thomas B. Casale, Jean‐Louis Vincent, Rekha Garg and Mark D. Williams. Their work appears in journals such as Journal of Allergy and Clinical Immunology, CHEST Journal, Annals of Allergy Asthma & Immunology, The Journal of Allergy and Clinical Immunology In Practice and Respiratory Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact